1. Introduction {#sec1}
===============

Bifurcation disease remains a challenging lesion subset posing a higher risk of adverse events in the drug-eluting stent (DES) era \[[@B1], [@B2]\]. Although use of the provisional 1-stent technique has been widely recommended for percutaneous coronary intervention (PCI) of bifurcation lesions \[[@B3]--[@B6]\], the 2-stent technique is frequently necessary and justified \[[@B7]\], especially in left main (LM) bifurcation disease because of the importance of preserving the left circumflex (LCX) artery \[[@B8]\]. Among the potential factors affecting clinical outcomes of LM bifurcation PCI, bifurcation angle has drawn interventionists\' interest. However, its impact has not yet been fully elucidated. Practically, one of the important factors in the stent strategy selection process is bifurcation angle: for example, T-stenting is considered appropriate for bifurcation with a near 90° angle between the main branch (MB) and side branch (SB) \[[@B3]\]. However, this practice is based on theoretical assumption without thorough validation using real-world data. Moreover, a few previous studies regarding bifurcation angle used heterogeneous definitions of the angle and reported controversial data \[[@B9]--[@B17]\]. Here, we sought to comprehensively assess the clinical impact of 3 different bifurcation angles (angles between the LM and the left anterior descending (LAD) artery, between the LM and the LCX, and between the LAD and the LCX) in patients undergoing LM bifurcation PCI using the 2-stent technique. Because visual estimation is widely adopted to assess bifurcation angles and determine a type of 2-stent technique in real-world practice, we used 2-dimensional quantitative coronary angiography (QCA) to measure bifurcation angles, results of which should be applied to daily practice.

2. Materials and Methods {#sec2}
========================

2.1. Study Population {#sec2.1}
---------------------

We analyzed patient-level pooled data from 4 multicenter registries in South Korea ([Figure 1](#fig1){ref-type="fig"}). The COBIS (COronary BIfurcation Stenting) II registry ([NCT01642992](https://clinicaltrials.gov/ct2/show/NCT01642992)) is a retrospective multicenter registry of individuals with coronary bifurcation lesions who underwent PCI with DES. Consecutive patients from 19 major coronary intervention centers in Korea were enrolled in this study between 2003 and 2010. The inclusion criteria were (1) age ≥18 years; (2) coronary bifurcation lesions treated with DES; and (3) a side branch or LCX reference diameter ≥2.3 mm and at least stentable with a 2.5 mm stent. The exclusion criteria were (1) protected LM disease (previous coronary artery bypass grafting in the LAD or LCX territory); (2) cardiogenic shock; and (3) history of cardiopulmonary resuscitation in the same hospitalization. The Seoul National University Hospital (SNUH) LM registry is a retrospective registry of patients undergoing PCI of bifurcation lesions at SNUH. From 2010 through 2015, a total of 565 patients were enrolled in this registry. The EXCELLENT (Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing) Registry ([NCT00960648](https://clinicaltrials.gov/ct2/show/NCT00960648)) and RESOLUTE-Korea (Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent) ([NCT00960908](https://clinicaltrials.gov/ct2/show/NCT00960908)) are multicenter prospective registries that consecutively enrolled 3,056 patients treated with everolimus-eluting stents (Xience V/Promus) from 29 centers (not sirolimus-eluting stents (Cypher)) and 1,998 patients treated with zotarolimus-eluting stents (Endeavor Resolute) from 25 centers, respectively, from 2008 through 2010. A total of 462 consecutive patients with LM bifurcation disease who underwent PCI using 2-stent strategies were identified: 181 were treated with the crush technique (22.2% classic, 63.2% mini-crush, and 14.6% other crush technique), 167 with T-stenting technique (14.4% classic T-stenting, 84.8% modified T or T and protrusion (TAP), and 0.8% inverted T-stenting), 32 with the culotte technique, and 81 with the kissing technique ([Figure 1](#fig1){ref-type="fig"}). This study complied with the provisions of the Declaration of Helsinki. The study protocol was approved by the institutional review board of each participating center. All patients provided written informed consent.

2.2. PCI Procedure {#sec2.2}
------------------

Coronary intervention was performed according to current standard procedural guidelines. The treatment strategy, details of the antiplatelet regimen, use of intravascular ultrasound, and choice of the specific DES type were left to the operator\'s discretion.

2.3. Definitions and Outcomes {#sec2.3}
-----------------------------

The primary outcome was target lesion failure (TLF), a composite of cardiac death, myocardial infarction (MI), or target lesion revascularization (TLR). Secondary outcomes were patient-oriented composite outcome (POCO, a composite of all-cause death, any MI, stroke or any revascularization, individual elements of TLF and POCO, target vessel revascularization (TVR), and definite or probable stent thrombosis according to the Academic Research Consortium definitions.

To reflect real-world practice, bifurcation angle was measured in an angiographic view with clear separation of bifurcation and least foreshortening, usually the left anterior oblique (LAO) caudal view. First, virtual lines were drawn as vectors extending from the branch origin. Next, the angles between LM and LAD (LM-LAD, angle C according to the European Bifurcation Club definition \[[@B18]\]), LAD and LCX (LAD-LCX, angle B), and LM and LCX (LM-LCX, angle A) were measured ([Figure 2](#fig2){ref-type="fig"}). The bifurcation angles were measured from preprocedural angiographic images. These bifurcation angles were independently assessed by 2 different cardiologists. The coefficient of variations (CVs) was calculated to determine the interobserver reliabilities for each bifurcation angle. Each CV was 20.0, 26.7, and 16.7, for the angle between LM and LCX, the angle between LAD and LCX, and the angle between LM and LAD, respectively, in our laboratory. The interobserver agreement for agreement on the wide angle between LM and LAD was 81.7% (Cohen\'s kappa = 0.553). The definition of procedural success was defined as a final residual stenosis \<30% with TIMI flow grade 3 in either the main branch or the side branch.

2.4. Statistical Analysis {#sec2.4}
-------------------------

Data are expressed as numbers and percentages for categorical variables and as mean ± standard deviation (SD) for continuous variables. The differences in characteristics between groups were compared using chi-square tests for categorical variables and Student\'s *t*-test or one-way analysis of variance for continuous variables. Regarding categorical variables, the Fisher exact test was used when any expected cell count was less than 5 (not resulting from missing rows or columns in a larger table). To determine the best cutoff bifurcation angle to predict TLF, receiver operating characteristic (ROC) curve analysis was performed. In order to get the optimal cutoff values, we used the Youden index (= Sensitivity + Specificity − 1). The time-dependent event rate was estimated by the Kaplan--Meier method and compared with the log-rank test. If the combined end points occurred in one patient, the first event was counted. The Cox proportional hazard model was used to calculate the hazard ratios (HRs) for the endpoints. A multivariable Cox regression model was used to adjust for uneven distribution of baseline characteristics and to find independent predictors of the clinical outcome. Variables with *P* \< 0.25 in the univariate analysis were included in multivariable Cox regression model. The final included variables are as follows: in the crush group, wide angle of LM-LAD (≥152°), MV calcification, long SB lesion (\>5 mm), high SYNTAX score (≥33), final kissing ballooning (FKB), and true bifurcation And in the T-stenting group, current smoker, low LV systolic function (\<50%), MV calcification, and long SB lesion (\>5 mm). The final models were determined by the enter method. Results are reported as 95% confidence intervals (CIs). A two-sided value of *P* \< 0.05 was considered significant for all probability values. SPSS version 22 (IBM SPSS Statistics, Chicago, IL, USA) was used for the statistical analyses.

3. Results {#sec3}
==========

3.1. Baseline Clinical, Angiographic, and Procedural Characteristics {#sec3.1}
--------------------------------------------------------------------

Of the 462 patients, 37% took the 2^nd^ generation DES, and the remainder, the 1^st^ generation DES. Because the majority of the study population underwent PCI using the crush technique or T-stenting, our study focused on these techniques. Baseline characteristics were similar between the crush technique and T-stenting group except for clinical manifestations: the acute coronary syndrome rate was higher in the crush group (crush versus T-stenting; 72.4% versus 54.5%; *P* \< 0.001) ([Table 1](#tab1){ref-type="table"}). Interestingly, although the choice between crush and T-stenting is generally determined based on LAD-LCX angle, the data from this real-world patient-level pooled registry showed no differences in bifurcation angles between the 2 groups (LM-LAD, 150.0 versus 155.2; *P*=0.061, LM-LCX, 121.1 versus 120.8; *P*=0.215, LAD-LCX, 82.0 versus 80.1; *P*=0.505, crush versus T-stenting, respectively).

The median follow-up duration was 1,048 days (interquartile range (IQR), 641--1,578) for the whole population, 1,050 days (IQR, 671--1,598) for the crush group, and 1,095 days (IQR, 728--1,577) for the T-stenting group. ROC curve analysis revealed that an LM-LAD bifurcation angle of 152° is the best cutoff value to predict TLF in the crush group (area under the curve, 0.628; 95% CI, 0.552 to 0.698; *P*=0.011) ([Figure 3](#fig3){ref-type="fig"}). No significant cutoffs were found in other angles in the crush group. In contrast, no cutoff values were identified to predict TLF in any angles in the T-stenting group. Among patients receiving the crush technique, the prevalence of dyslipidemia was higher in the LM-LAD ≥152° group ([Table 2](#tab2){ref-type="table"}). Among patients receiving T-stenting, the prevalence of hypertension and previous MI were higher in the LM-LAD ≥152° group than in the \<152° group. Other clinical characteristics were not statistically different between the 2 groups in each technique. Angiographic and procedural characteristics were statistically similar between the 2 groups in each technique except for main vessel (MV) calcification in the crush technique and bifurcation angles in both ([Table 3](#tab3){ref-type="table"}).

3.2. Clinical Outcomes Depending on Bifurcation Angles in Each Technique {#sec3.2}
------------------------------------------------------------------------

TLF more frequently occurred in the LM-LAD angle ≥152° group than in the \<152° group among patients treated with the crush technique (LM-LAD angle ≥152° versus \<152°; 35.7% versus 14.6%, respectively; adjusted HR, 3.476; 95% CI, 1.612 to 7.492; *P*=0.001). In contrast, the incidence of TLF was not affected by an LM-LAD angle ≥152° or \<152° in patients treated with the T-stenting technique (LM-LAD angle ≥152° versus \<152°; 20.4% versus 22.5%; adjusted HR, 0.730; 95% CI, 0.200 to 2.663; *P*=0.633) ([Figure 4(a)](#fig4){ref-type="fig"}, [Table 4](#tab4){ref-type="table"}). The incidences of POCO, any revascularization, TLR, and TVR were significantly higher in the LM-LAD angle ≥152° group among patients treated with the crush technique. However, the incidences of other clinical outcomes were also similar between the 2 groups of patients treated with the T-stenting technique ([Table 4](#tab4){ref-type="table"}). TLR occurred in 19.3% (*n* = 35) and 14.4% (*n* = 24) of the crush group and T-stenting group, respectively (*P*=0.213). Among the patients whose location of TLR sites was available, there were no statistical differences in TLR sites between the LM-LAD angle ≥152° and \<152° group (Supplementary [Table 1](#supplementary-material-1){ref-type="supplementary-material"}). When the crush technique was compared with T-stenting in the LM-LAD angle ≥152° and \<152° group, respectively, the crush technique showed a higher tendency of TLF than T-stenting in the LM-LAD angle ≥152° group (Supplementary [Figure 1](#supplementary-material-1){ref-type="supplementary-material"}).

In real-world practice, interventionists choose between T-stenting and crush techniques based on LAD-LCX angle, not LM-LAD. For bifurcation lesions with a LAD-LCX angle close to a right angle, the so-called wide LAD-LCX angle, T-stenting is preferred. In contrast, for a lesion with a narrow LAD-LCX angle, the crush technique is preferred. In this regard, the whole study population was reclassified by an LAD-LCX angle of 70°. However, the data showed that the incidence of TLF was not affected by an LAD-LCX angle ≥70° or \<70° using either technique ([Figure 4(b)](#fig4){ref-type="fig"}).

Multivariable regression analysis revealed that an LM-LAD angle ≥152° was an independent predictor of TLF in the crush technique, whereas MV calcification was independent predictors of TLF in the T-stenting technique ([Table 5](#tab5){ref-type="table"}). Neither the type of bifurcation (true or nontrue) nor generation of stent was an independent predictor of TLF in both techniques.

4. Discussion {#sec4}
=============

To our knowledge, this is the first study to comprehensively evaluate the impact of 3 bifurcation angles in patients with LM bifurcation disease using the 2-stent strategy. The main findings of our study are as follows: (1) wide LM-LAD angle (≥152°) is associated with poor outcomes in LM bifurcation PCI using the crush technique and (2) outcomes of T-stenting in LM bifurcation lesion were not affected by any bifurcation angle.

There are several critical limitations in previous studies regarding angles of bifurcation PCI. First, bifurcation angle in other studies did not mean the same angle. Some studies referred to the angle between the MB and the SB (angle B) \[[@B16], [@B17], [@B19], [@B20]\], while others focused on the angle between the MV and the SB (angle A) \[[@B21]\]. Second, most dealt with non-LM bifurcation lesions \[[@B9], [@B16], [@B22], [@B23]\]. Third, some analyzed data from patients treated with the 1-stent strategy \[[@B24]\]. Fourth, all studies that suggested the bifurcation angle cutoff value for predicting poor outcomes arbitrarily selected the angles. Fifth, timing of measuring the angles (i.e., the systolic or diastolic phase, before or after PCI) was not standardized or specified in previous studies. As a result, previous studies showed mixed results as follows:

Dzavik et al. demonstrated that wide bifurcation angle (≥50°) was an independent predictor of major adverse cardiovascular events (MACE), a composite of death, MI, and TLR, in 133 patients treated with the crush technique \[[@B9]\]. In this study, only 6.0% of patients had LM disease. Furthermore, among them, it is unclear how many cases had LM disease as a main target for bifurcation PCI. A bifurcation angle of 50° was selected to stratify the study population because it was a median angle. This article is one of the earliest studies of angle in bifurcation PCI. Thereafter, it has been referred to in many articles as a study showing a negative impact of wide bifurcation angle between the MB and the SB (angle B). In fact, according to Section 2 of the article, this study defined the bifurcation angle as an angle between the MV and the SB (angle A). Thus, a bifurcation angle ≥50° in this study actually meant angle *A* \< 130°. The same group also showed that a wide bifurcation angle (≥50°) was associated with a lower rate of MACE (death, MI, or TVR) for Canadian Cardiovascular Society (CCS) class ≥2 angina-free survival in patients treated with crush or Culotte stenting (*n* = 140) \[[@B10]\]. Only 5.7% of patients had LM disease as the main bifurcation target. Interestingly, outcomes of patients with MV stenting only (*n* = 266) were not affected by bifurcation angle. Again, although this study has been frequently misinterpreted as the one focusing on angle B (between the MB and the SB), it actually studied angle A (between the MV and the SB). Therefore, a bifurcation angle ≥50° in this study indicated an angle *A* \< 130°. In the other study performed by the same group \[[@B11]\], the authors again demonstrated that a wide bifurcation angle (≥50°), indicating an angle *A* \< 130°, was associated with a lower risk of MACE (death, MI, or TVR) or CCS class ≥2 angina in patients treated with crush or Culotte stenting (*n* = 360). Of the cohort, 3.1% of patients had LM disease as a main bifurcation target.

Adriaenssens et al. revealed that an increasing angle B (between the MB and the SB) was an independent predictor of angiographic restenosis in patients undergoing Culotte stenting (*n* = 134) \[[@B12]\]. This study excluded bifurcation interventions in the LM artery. Chen et al. analyzed 37 patients with unprotected LM bifurcation lesions treated with crush or double kissing (DK) crush stenting \[[@B13]\]. The data showed that an increasing bifurcation angle B (between the MB and the SB) was an independent predictor of TLR. The same group also demonstrated that an increasing bifurcation angle B was associated with a higher risk of MACE (cardiac death, MI, or TLR) in patients treated with crush stenting in another study (*n* = 230) \[[@B14]\]. This study included 33 cases (14.3%) of LM bifurcation interventions.

Interestingly, the same group compared the impact of a wide bifurcation angle B (≥60°) and narrow-angle B (\<60°) in patients treated with crush or DK crush stenting (*n* = 220) in the other study and found that bifurcation angle B did not influence the clinical outcomes including MACE (cardiac death, MI, or TLR) \[[@B15]\]. A total of 15.2% of the study population underwent LM bifurcation intervention in this study. Yang et al. divided the patients undergoing bifurcation PCI into wide- and narrow-angle groups using median bifurcation angle B (50°) in their study (*n* = 1,432) \[[@B16]\]. The incidences of MACE (cardiac death, MI, or TLR) and TLR were not significantly different between the 2 groups. Although the study population was relatively large, this study focused on only non-LM bifurcation lesions. Furthermore, the vast majority of patients (84.5%) were treated with the 1-stent technique. Girasis et al. stratified the patients receiving LM bifurcation PCI by tertiles of angle B (\<82°, 82--106°, ≥107°) \[[@B17]\]. The results showed that angle B did not affect the rate of major adverse cardiac and cerebrovascular events (a composite of all-cause death, cerebrovascular accident, MI, or repeat revascularization) in patients treated with 1 stent (*n* = 75) and those treated with ≥2 stents (*n* = 110).

In summary, previous studies reported mixed results with mixed definitions of bifurcation angle.

The current study comprehensively analyzed the impact of each of 3 bifurcation angles on clinical outcomes in patients receiving LM bifurcation PCI with DES using the major 2-stent techniques (crush and T-stenting). Our data revealed that a wide LM-LAD (angle C) was an independent predictor of worse outcomes in the crush technique, whereas bifurcation angle did not affect the T-stenting outcomes. The cutoff value of an LM-LAD of 152° for predicting TLF was statistically determined using ROC curve analysis.

The current practical guides recommend a provisional approach with a simple crossover technique using a 1-stent rather than an upfront 2-stent technique \[[@B3], [@B25]\]. However, considering the diameter of the LCX artery, the area it supplies, and the significance of its flow preservation, an LM bifurcation lesion is the bifurcation where the need for use of the 2-stent strategy is underscored compared to other bifurcations. Our study provides useful information for LM bifurcation PCI using the 2-stent technique.

The reason why a wide LM-LAD angle (≥152°) is associated with poor crush technique outcomes is unclear. The first possible explanation for our findings is the potential uneven expansion of kissing balloons. In bifurcation lesions with a wide LM-LAD angle, a kissing balloon in LM-LAD can be easily straightened, whereas a bending force may be placed on the opposite side of a balloon in LM-LCX, resulting in uneven expansion. This effect may be prominent in the crush technique, in which the optimization of crushed struts may be more important than in T-stenting. Although FKB was not a predictor of events ([Table 5](#tab5){ref-type="table"}) in the crush group, it may be because kissing ballooning could not be adequately performed in patients taking FKB. Second, crush of the side branch stent in the bifurcation with a wide LM-LAD angle could be incomplete due to weak force of the straightened balloon ([Figure 5(a)](#fig5){ref-type="fig"}). Third, in the bifurcation with a wide LM-LAD angle, relatively lower shear stress area could be generated in the lateral side of LM where the crushed stent struts are located ([Figure 5(a)](#fig5){ref-type="fig"}). In contrast, in the bifurcation with a narrow LM-LAD angle, shear stress could be ideally distributed ([Figure 5(b)](#fig5){ref-type="fig"}). All these potential mechanisms are hypotheses from scientific speculation which need validation with further studies.

5. Limitations {#sec5}
==============

The current study has some limitations. First, because this study was based on registry data, there are intrinsic limitations of nonrandomized comparisons including biased distribution of risk factors and lesion characteristics and possible influences of unmeasured confounding factors despite multivariable adjustment. Second, the selection of stenting techniques was left entirely to the operator\'s discretion, reflecting the registry nature of our study. This may cause selection bias, although clinical, angiographic, and procedural characteristics were fairly evenly distributed across the groups (Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"}). In addition, the outcomes of LM bifurcation PCI could be dependent on the expertise of the operator. However, this variable was not available in our pooled registry. Third, we used 2-dimensional QCA to measure bifurcation angles. Three-dimensional QCA was recently suggested as a useful tool for the accurate and precise measurement of bifurcation angles. However, we think that 2-dimensional QCA may better reflect the results of daily practice since visual estimation remains the most frequently and widely adopted method in the real world. Fourth, this study was conducted with relatively small numbers of study population. However, to our knowledge, this is the largest study investing the impact of bifurcation angles in LM bifurcation treated with the two-stent technique. Fifth, about two-thirds of the study population in our study received the 1^st^ generation DES. Although multivariable regression analysis showed the generation of DES was not an independent predictor of TLF ([Table 5](#tab5){ref-type="table"}), high proportion of the 1^st^ generation DES may not reflect good outcomes of the current practice. Lastly, the underlying mechanisms for poor outcomes in a wide LM-LAD angle were limited. Further studies using *in vitro* or *in silico* models are warranted.

6. Conclusions {#sec6}
==============

In patients undergoing LM bifurcation PCI using the 2-stent technique with DES, a wide LM-LAD angle (≥152°) was associated with a greater risk of TLF in patients treated with the crush technique, mainly driven by an increased TLR rate, whereas none of the bifurcation angles affected T-stenting outcomes.
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*Supplementary Table 1*. Target lesion revascularization sites in each left main bifurcation group. *Supplementary Figure 1*. TLF according to the stent techniques in patients with wide (≥152°) and narrow LM-LAD angle (\<152°).
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![Study population from 4 multicenter registries. EES, everolimus-eluting stent(s); LM, left main; PCI, percutaneous coronary intervention; TAP, T and protrusion; ZES-R, zotarolimus-eluting resolute stent.](JITC2020-2475930.001){#fig1}

![Measurement of left main bifurcation angles. Virtual lines were drawn from the branch origin under the LAO caudal view, and the 3 bifurcation angles were measured. LAD, left anterior descending artery; LAO, left anterior oblique; LCX, left circumflex artery; and LM, left main.](JITC2020-2475930.002){#fig2}

![Receiver operating characteristic curves showing sensitivity of each angle for predicting TLF risk in patients treated with (a) crush and (b) T-stenting technique. An LM-LAD angle of 152° was the best cutoff value for predicting TLF in the crush group. None of the bifurcation angles had a significant cutoff value in the T-stenting group. AUC, area under the curve; BCV, best cutoff value; CI, confidence interval; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main; TLF, target lesion failure.](JITC2020-2475930.003){#fig3}

![Clinical impact of bifurcation angle after LM PCI using the crush technique versus T-stenting. (a) The clinical impact of LM-LAD angle after left main percutaneous coronary intervention using the crush technique versus T-stenting. (b) The clinical impact of the LAD-LCX angle after left main percutaneous coronary intervention using the crush technique versus T-stenting. HR, hazard ratio; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main; and PCI, percutaneous coronary intervention. The left column represents the crush strategy, and the right column represents the T-stenting strategy.](JITC2020-2475930.004){#fig4}

![Schematic diagrams of LM bifurcation according to different LM-LAD angles. Blue ovals mean the balloon catheter, gray rectangles mean the stent, and arrows indicate wall shear stress. (a) Wide LM-LAD angle. (b) Narrow LM-LAD angle. LAD, left anterior descending artery; LCX, left circumflex artery; and LM, left main.](JITC2020-2475930.005){#fig5}

###### 

Baseline clinical, angiographic, and procedural characteristics of the study population.

  Clinical characteristics                        Total (*n* = 348)      Crush (*n* = 181)      T-stenting (*n* = 167)   *P* value
  ----------------------------------------------- ---------------------- ---------------------- ------------------------ -----------
  Age, years                                      64.4 ± 10.0            64.4 ± 9.9             64.5 ± 10.2              0.944
  Male                                            207 (59.5)             110 (60.8)             97 (58.1)                0.610
  Diabetes mellitus                               112 (32.2)             59 (32.6)              53 (31.7)                0.864
  Hypertension                                    203 (58.3)             107 (59.1)             96 (57.5)                0.758
  Dyslipidemia                                    105 (30.2)             47 (26.0)              58 (34.7)                0.075
  Peripheral vascular disease                     9 (2.6)                5 (2.8)                4 (2.4)                  1.000
  Chronic kidney disease^*∗*^                     30 (8.6)               19 (10.5)              11 (6.6)                 0.194
  Current smoker                                  74 (21.3)              42 (23.2)              32 (19.2)                0.357
  Previous myocardial infarction                  27 (7.8)               16 (8.8)               11 (6.6)                 0.433
  Previous cerebrovascular event                  29 (8.3)               18 (9.9)               11 (6.6)                 0.258
  Previous PCI                                    79 (22.7)              47 (26.0)              32 (19.2)                0.130
  Previous CABG                                   6 (1.7)                4 (2.2)                2 (1.2)                  0.686
  Family history of CAD                           15 (4.3)               8 (4.4)                7 (4.2)                  0.917
  LV ejection fraction, %                         58.2 ± 11.8            58.7 ± 12.2            57.5 ± 11.2              0.411
  *Clinical Manifestation*                                                                                               0.005
  STEMI                                           22 (6.3)               11 (6.1)               11 (6.6)                  
  NSTEMI                                          35 (10.1)              26 (14.4)              9 (5.4)                   
  Unstable angina                                 165 (47.4)             94 (51.9)              71 (42.5)                 
  Stable angina                                   117 (33.6)             47 (26.0)              70 (41.9)                 
  Silent ischemia                                 8 (2.3)                3 (1.7)                5 (3.0)                   
                                                                                                                         
  *Angiographic and Procedural Characteristics*                                                                          
  Angle of LM-LAD                                 152.4 (135.0--166.0)   150.0 (134.0--165.9)   155.2 (138.0--166.3)     0.061
  Angle of LM-LCX                                 121.0 (105.4--137.0)   121.1 (106.6--139.1)   120.8 (105.0--136.2)     0.215
  Angle of LAD-LCX                                81.0 (64.0--102.0)     82.0 (64.0--105.0)     80.1 (64.2--101.0)       0.505
  *SYNTAX Score*                                                                                                         0.019
  Low score (0--22)                               120 (34.7)             59 (32.6)              61 (37.0)                 
  Intermediate score (23--32)                     151 (43.6)             72 (39.8)              79 (47.9)                 
  High score (≥33)                                75 (21.7)              50 (39.8)              25 (15.2)                 
  *Medina classification*                                                                                                0.084
  *True Bifurcation*                                                                                                      
  1.1.1                                           161 (46.4)             76 (42.0)              85 (50.9)                 
  1.0.1                                           33 (9.5)               21 (11.6)              12 (7.2)                  
  0.1.1                                           66 (14.3)              22 (12.2)              27 (16.2)                 
  *Nontrue Bifurcation*                                                                                                  
  1.0.0                                           9 (2.6)                4 (2.2)                5 (3.0)                   
  0.1.0                                           26 (7.5)               16 (8.8)               10 (6.0)                  
  1.1.0                                           38 (11.0)              17 (9.4)               21 (12.7)                 
  0.0.1                                           31 (9.3)               25 (13.8)              6 (3.6)                   
  *DES Type*                                                                                                             0.146
  SES                                             151 (43.4)             81 (44.8)              70 (41.9)                 
  PES                                             63 (18.1)              33 (18.2)              30 (18.0)                 
  ZES                                             58 (16.7)              26 (14.4)              32 (19.2)                 
  EES                                             56 (16.1)              34 (18.8)              22 (13.2)                 
  BP-BES                                          18 (5.2)               6 (3.3)                12 (7.2)                  
  *Stent Type*                                                                                                           0.636
  First generation DES                            217 (62.4)             115 (63.5)             102 (61.1)                
  Second generation DES                           131 (37.6)             66 (36.5)              65 (38.9)                 
  LAD stent diameter                              3.4 ± 0.4              3.4 ± 0.4              3.4 ± 0.4                0.167
  LCX stent diameter                              3.0 ± 0.4              3.0 ± 0.4              3.1 ± 0.4                0.047

Values are mean ± SD, median (interquartile ranges, 25^th^--75^th^), or *n* (%) (per-patient analysis). ^*∗*^Chronic kidney disease defined as a glomerular filtration rate (GFR) \< 60 ml/min/1.73 m^2^. BP-BES, biodegradable polymer biolimus-eluting stent; CABG, coronary artery bypass grafting; CAD, coronary artery disease; DES, drug-eluting stent; EES, everolimus-eluting stent; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main; LV, left ventricle; NSTEMI, non-ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent; SES, sirolimus-eluting stent; STEMI, ST-segment elevation myocardial infarction; ZES, zotarolimus-eluting stent.

###### 

Baseline clinical characteristics in patients treated with the 2-stent technique using the crush technique or T-stenting in LM bifurcation.

                                   Crush (*n* = 181)   T-stenting (*n* = 167)                                      
  -------------------------------- ------------------- ------------------------ ------- ------------ ------------- -------
  Age, years                       63.1 ± 11.1         65.4 ± 8.6               0.124   65.0 ± 9.0   64.0 ± 11.5   0.535
  Male                             55 (65.5)           54 (56.3)                0.224   57 (61.3)    37 (52.1)     0.239
  Diabetes mellitus                24 (28.6)           35 (36.5)                0.271   33 (35.5)    18 (25.4)     0.165
  Hypertension                     48 (57.1)           58 (60.4)                0.384   60 (64.5)    35 (49.3)     0.050
  Dyslipidemia                     28 (33.3)           19 (19.8)                0.029   30 (32.3)    27 (38.0)     0.442
  Peripheral vascular disease      2 (2.4)             3 (3.1)                  1.000   4 (4.3)      0 (0)         0.134
  Chronic kidney disease^*∗*^      7 (8.3)             12 (12.5)                0.468   6 (6.5)      5 (7.0)       1.000
  Current smoker                   23 (27.4)           19 (19.8)                0.289   22 (23.7)    9 (12.7)      0.075
  Previous myocardial infarction   5 (6.0)             11 (11.5)                0.294   10 (10.8)    1 (1.4)       0.024
  Previous cerebrovascular event   10 (11.9)           8 (8.3)                  0.464   6 (6.5)      4 (5.6)       1.000
  Previous PCI                     20 (23.8)           27 (28.1)                0.610   22 (23.7)    10 (14.1)     0.125
  Previous CABG                    2 (2.4)             2 (2.1)                  1.000   2 (2.2)      0 (0)         0.506
  Family history of CAD            4 (4.8)             4 (4.2)                  1.000   4 (4.3)      2 (2.8)       0.699
  LV ejection fraction, %          59.8 ± 12.4         57.8 ± 12.1              0.310   57.9 ± 9.7   57.9 ± 12.6   0.985
  *Clinical Manifestation*                                                      0.359                              0.645
  STEMI                            7 (8.3)             4 (4.2)                          7 (7.5)      4 (5.6)        
  NSTEMI                           13 (15.5)           13 (13.5)                        6 (6.5)      2 (2.8)        
  Unstable angina                  41 (48.8)           41 (54.2)                        41 (44.1)    30 (42.3)      
  Stable angina                    23 (27.4)           27 (28.1)                        39 (42.0)    31 (43.7)      

Values are mean ± standard deviations, median (interquartile ranges, 25^th^--75^th^), or *n* (%) (per-patient analysis). ^*∗*^Chronic kidney disease defined as a glomerular filtration rate (GFR) \< 60 ml/min/1.73 m^2^. CABG, coronary artery bypass grafting; CAD, coronary artery disease; LAD, left anterior descending artery; LM, left main; LV, left ventricle; NSTEMI, non-ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction.

###### 

Angiographic and procedural characteristics in patients treated with the 2-stent technique using the crush technique or T-stenting in LM Bifurcation.

                                         Crush                  T-stenting                                                                     
  -------------------------------------- ---------------------- ---------------------- --------- ---------------------- ---------------------- ---------
  Angle of LM-LAD                        166.4 (158.5--175.1)   134.0 (120.5--143.2)   \<0.001   165.0 (157.6--173.3)   136.1 (125.0--142.0)   \<0.001
  Angle of LM-LCX                        116.2 (104.1--131.8)   125.5 (108.7--143.0)   0.009     120.1 (104.0--132.7)   121.0 (107.0--137.0)   0.495
  Angle of LAD-LCX                       68.3 (55.8--86.7)      94.5 (79.5--116.5)     \<0.001   71.9 (60.4--85.1)      96.0 (76.1--109.8)     \<0.001
  *SYNTAX Score*                                                                       0.972                                                   0.690
  Low score (0--22)                      27 (32.1)              31 (32.2)                        32 (34.8)              28 (40.0)               
  Intermediate score (23--32)            33 (39.3)              39 (40.6)                        47 (51.1)              31 (44.3)               
  High score (≥33)                       24 (28.6)              26 (27.1)                        13 (14.1)              11 (15.7)               
  *Medina Classification*                                                              0.603                                                   0.475
  True bifurcation                                                                                                                              
  1.1.1                                  38 (45.2)              38 (39.6)                        42 (45.2)              42 (59.2)               
  1.0.1                                  10 (11.9)              11 (11.5)                        7 (7.5)                5 (7.0)                 
  0.1.1                                  9 (10.7)               13 (13.5)                        18 (19.4)              9 (12.7)                
  Nontrue bifurcation                                                                                                                           
  1.0.0                                  2 (2.4)                2 (2.1)                          2 (2.2)                2 (2.8)                 
  0.1.0                                  6 (7.1)                10 (10.4)                        7 (7.5)                3 (4.2)                 
  1.1.0                                  5 (6.0)                12 (12.5)                        12 (12.9)              8 (11.3)                
  0.0.1                                  14 (16.7)              10 (10.4)                        5 (5.4)                1 (1.4)                 
  *DES Type*                                                                           0.609                                                   0.775
  SES                                    40 (47.6)              41 (42.7)                        43 (46.2)              27 (38.0)               
  PES                                    18 (21.4)              15 (15.6)                        15 (16.1)              15 (21.1)               
  ZES                                    9 (10.7)               16 (16.7)                        13 (14.3)              9 (12.7)                
  EES                                    15 (17.9)              19 (19.8)                        15 (16.1)              14 (19.7)               
  BP-BES                                 0 (0)                  1 (1.0)                          6 (6.5)                6 (8.5)                 
  *Stent Type*                                                                         0.267                                                   0.442
  First generation DES                   60 (71.4)              60 (62.5)                        63 (67.7)              44 (62.0)               
  Second generation DES                  24 (28.6)              36 (37.5)                        30 (32.3)              27 (38.0)               
  LAD stent diameter                     3.4 ± 0.4              3.5 ± 0.4              0.408     3.4 ± 0.4              3.4 ± 0.4              0.655
  LCX stent diameter                     3.0 ± 0.3              3.0 ± 0.3              0.990     3.2 ± 0.5              3.2 ± 0.4              0.410
  IVUS-guided PCI                        53 (63.1)              53 (55.2)              0.293     66 (71.0)              49 (69.0)              0.787
  Rotablation                            0 (0)                  1 (1.0)                1.000     1 (1.1)                1 (1.4)                1.000
  Final kissing ballooning               65 (83.3)              73 (83.0)              0.948     73 (90.1)              60 (96.8)              0.187
  Conversion from provisional stenting   0/76 (0)               3/75 (4.0)             0.120     60/79 (75.9)           47/53 (88.7)           0.067
  Main vessel procedural success         84/84 (100.0)          95/96 (99.0)           1.000     93/93 (100.0)          70/70 (100.0)          NA
  Side branch procedural success         84/84 (100.0)          95/96 (99.0)           1.000     93/93 (100.0)          68/70 (97.1)           0.183
  *Preintervention QCA*                                                                                                                         
  MV RD, mm                              3.2 ± 0.4              3.2 ± 0.5              0.602     3.3 ± 0.5              3.2 ± 0.6              0.718
  SB RD, mm                              2.6 ± 0.4              2.7 ± 0.4              0.262     2.9 ± 0.5              2.7 ± 0.6              0.114
  MV MLD, mm                             1.2 ± 0.6              1.2 ± 0.6              0.719     1.2 ± 0.6              1.1 ± 0.5              0.324
  SB MLD, mm                             1.2 ± 0.6              1.1 ± 0.6              0.572     1.3 ± 0.6              1.1 ± 0.5              0.055
  MV diameter stenosis, %                62.1 ± 17.2            64.4 ± 16.0            0.359     62.2 ± 18.1            64.8 ± 17.8            0.354
  SB diameter stenosis, %                56.2 ± 20.5            59.4 ± 20.5            0.306     54.1 ± 19.4            58.5 ± 18.4            0.161
  MV lesion length, mm                   21.5 ± 17.5            25.4 ± 20.3            0.175     20.4 ± 14.0            20.1 ± 14.9            0.911
  SB lesion length, mm                   12.8 ± 11.4            12.6 ± 11.8            0.919     9.9 ± 10.4             11.9 ± 12.3            0.260
  MV calcification                       22 (26.2)              42 (43.8)              0.019     36 (38.7)              28 (40.0)              0.867
  SB calcification                       15 (17.9)              21 (21.9)              0.577     21 (22.6)              14 (20.0)              0.671
  *Postintervention QCA*                                                                                                                        
  MV RD, mm                              3.2 ± 0.5              3.2 ± 0.6              0.806     3.5 ± 0.6              3.3 ± 0.6              0.167
  SB RD, mm                              2.7 ± 0.5              2.7 ± 0.5              0.753     2.9 ± 0.5              2.8 ± 0.5              0.214
  MV MLD, mm                             2.8 ± 0.5              2.7 ± 0.5              0.492     2.7 ± 0.5              2.9 ± 0.6              0.521
  SB MLD, mm                             2.5 ± 0.5              2.5 ± 0.5              0.416     2.7 ± 0.6              2.6 ± 0.5              0.292
  MV diameter stenosis, %                14.6 ± 11.5            16.3 ± 11.8            0.387     15.3 ± 11.4            14.7 ± 9.7             0.765
  SB diameter stenosis, %                6.2 ± 17.8             7.9 ± 14.7             0.537     9.1 ± 13.8             8.3 ± 12.6             0.735

Values are mean ± standard deviations, median (interquartile ranges, 25^th^--75^th^), or *n* (%) (per-patient analysis). BP-BES, biodegradable polymer biolimus-eluting stent; DES, drug-eluting stent; EES, everolimus-eluting stent; IVUS, intravascular ultrasound; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main; MLD, minimal lumen diameter; MV, main vessel; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent; QCA, quantitative coronary angiography; RD, reference diameter; SB, side branch; SES, sirolimus-eluting stent; ZES, zotarolimus-eluting stent.

###### 

Adjusted hazard ratios of wide (≥152°) compared with narrow LM-LAD angle (\<152°) in patients treated with the crush technique and with T-stenting.

  *Crush strategy*                        LM-LAD angle ≥152°   LM-LAD angle \<152°   Adjusted HR (95% CI)     *P* value
  --------------------------------------- -------------------- --------------------- ------------------------ -----------
  Target lesion failure^*∗*^              30 (35.7)            14 (14.6)             3.476 (1.612--7.492)     0.001
  Patient-oriented composite outcome^†^   38 (45.2)            27 (28.1)             2.061 (1.126--3.772)     0.019
  All-cause death                         7 (8.3)              11 (11.5)             0.517 (0.126--2.118)     0.360
  Cardiac death                           5 (6.0)              3 (3.1)               4.661 (0.182--119.518)   0.352
  Spontaneous MI                          3 (3.6)              1 (1.0)               5.506 (0.118--257.567)   0.385
  Any revascularization                   31 (36.9)            17 (17.7)             2.849 (1.379--5.889)     0.005
  Target lesion revascularization         24 (28.6)            11 (11.5)             3.758 (1.602--8.817)     0.002
  Target vessel revascularization         30 (35.7)            14 (14.6)             2.404 (1.117--5.176)     0.025
  Definite or probable stent thrombosis   4 (4.8)              2 (2.1)               1.885 (0.203--17.534)    0.577
                                                                                                              
  *T-Stent Strategy*                                                                                           
  Target lesion failure^*∗*^              19 (20.4)            16 (22.5)             0.730 (0.200--2.663)     0.633
  Patient-oriented composite outcome^†^   26 (28.0)            27 (38.0)             0.745 (0.291--1.907)     0.539
  All-cause death                         12 (12.9)            9 (12.7)              0.714 (0.152--3.351)     0.669
  Cardiac death                           6 (6.5)              4 (5.6)               0.501 (0.024--10.478)    0.656
  Spontaneous MI                          3 (3.2)              2 (2.8)               0 (0-indefinite)         0.881
  Any revascularization                   17 (18.3)            17 (23.9)             1.326 (0.393--4.466)     0.649
  Target lesion revascularization         14 (15.1)            10 (14.1)             0.660 (0.118--3.686)     0.636
  Target vessel revascularization         17 (18.3)            15 (21.1)             1.578 (0.383--6.498)     0.527
  Definite or probable stent thrombosis   4 (4.3)              2 (2.8)               0.182 (0.002--18.727)    0.471

^*∗*^Target lesion failure defined as a composite of cardiac death, myocardial infarction, or target lesion revascularization. ^†^Patient-oriented composite outcomes defined as a composite of cardiac death, myocardial infarction, stroke, or any revascularization. Variables included in the Cox proportional hazard regression model were wide LM-LAD angle (≥152°), wide LAD-LCX angle (≥70°), diabetes mellitus, dyslipidemia, current smoker, low LV systolic function (\<50%), chronic kidney disease, acute coronary syndrome, main vessel calcification, long side branch lesion (\>5 mm), high SYNTAX score (≥33), and final kissing ballooning. CI, confidence interval; HR, hazard ratio; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main; LV, left ventricle; MI, myocardial infarction.

###### 

Independent predictors of TLF in patients treated with the crush technique and T-stenting.

                                     Univariable analysis   Multivariable analysis                       
  ---------------------------------- ---------------------- ------------------------ ------------------- -------
  *Crush Technique*                                                                                       
  Wide angle of LM-LAD (≥152°)       2.50 (1.32--4.73)      0.005                    2.57 (1.34--4.90)   0.004
  Wide angle of LAD-LCX (≥70°)       1.01 (0.54--1.90)      0.983                    ---                 ---
  Diabetes mellitus                  1.18 (0.63--2.19)      0.613                    ---                 ---
  Dyslipidemia                       1.27 (0.67--2.40)      0.461                    ---                 ---
  Current smoker                     0.96 (0.46--1.99)      0.907                    ---                 ---
  Low LV systolic function (\<50%)   1.27 (0.62--2.58)      0.509                    ---                 ---
  Chronic kidney disease             1.36 (0.53--3.47)      0.521                    ---                 ---
  Acute coronary syndrome            1.20 (0.63--2.28)      0.577                    ---                 ---
  MV calcification                   1.55 (0.85--2.81)      0.152                    1.60 (0.86--3.00)   0.138
  Long SB lesion (\>5 mm)            1.98 (0.92--4.26)      0.081                    1.57 (0.70--3.51)   0.275
  High SYNTAX score (≥33)            2.52 (1.16--5.46)      0.019                    1.80 (0.97--3.33)   0.062
  Final kissing ballooning           0.97 (0.41--2.34)      0.953                    ---                 ---
  IVUS-guided PCI                    0.95 (0.52--1.73)      0.874                    ---                 ---
  True bifurcation                   1.63 (0.82--3.22)      0.162                    1.28 (0.63--2.61)   0.501
  2^nd^ generation DES               1.42 (0.73--2.76)      0.308                    ---                 ---
                                                                                                         
  *T-stenting technique*                                                                                  
  Wide angle of LM-LAD (≥152°)       0.85 (0.44--1.67)      0.641                    ---                 ---
  Wide angle of LAD-LCX (≥70°)       1.53 (0.73--3.18)      0.258                    ---                 ---
  Diabetes mellitus                  0.97 (0.46--2.01)      0.926                    ---                 ---
  Dyslipidemia                       1.17 (0.59--2.33)      0.656                    ---                 ---
  Current smoker                     2.17 (1.04--4.52)      0.039                    1.94 (0.82--4.58)   0.129
  Low LV systolic function (\<50%)   2.33 (1.01--5.37)      0.047                    2.08 (0.86--5.00)   0.103
  Chronic kidney disease             1.50 (0.46--4.91)      0.506                    ---                 ---
  Acute coronary syndrome            0.83 (0.42--1.61)      0.578                    ---                 ---
  MV calcification                   2.31 (1.18--4.52)      0.014                    2.78 (1.20--6.41)   0.017
  Long SB lesion (\>5 mm)            1.81 (0.85--3.87)      0.125                    1.12 (0.47--2.70)   0.796
  High SYNTAX score (≥33)            1.68 (0.34--3.41)      0.912                    ---                 ---
  Final kissing ballooning           0.75 (0.18--3.17)      0.694                    ---                 ---
  IVUS-guided PCI                    0.94 (0.45--1.96)      0.859                    ---                 ---
  True bifurcation                   1.47 (0.64--3.36)      0.365                    ---                 ---
  2^nd^ generation DES               0.87 (0.44--1.72)      0.697                    ---                 ---

CI, confidence interval; DES, drug-eluting stent; HR, hazard ratio; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main; LV, left ventricle; MV, main vessel; SB, side branch; TLF, target lesion failure.
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